Search Results

Results for ""

2024年5-6月通訊

1. Message from CMEL Co-Director Prof Eric C. Ip 2. Letter to the Editor • "Existing and Emerging Capabilities in the Governance of Medical AI" 3. Journal Articles • "How the EU AI Act Seeks to Establish an Epistemic Environment of Trust" • "Championing Planetary Health: Cancer Nurses Paving the Path to a Vibrant Future" • "Digital Humans to Combat Loneliness and Social Isolation: Ethics Concerns and Policy Recommendations" •  Reply to “Colonial and Neocolonial Barriers to Companion Digital...

The Ethics and Regulation of Challenge Trials: The Ethics of Exposing People to Serious Diseases for Research Purposes

Abstract: Challenge Trials – a type of research study where people give consent to being exposed to a serious infectious disease so that researchers can better understand that disease – have actually been taking place for decades. And in their current form, they are not particularly controversial. They have been used to learn better ways to treat and prevent major diseases that still kill millions of people, such as malaria, cholera and influenza (the flu). This presentation will discuss the...

Medical & Surgical Decisions in Critically Ill Patients: Cross-Cultural Perspectives on Challenging Ethical Issues

Programme Rundown: 8:00-8:30AM          Registration 8:30-8:45AM          Welcome and Introductions 8:45-9:15AM          “Futility in Contemporary Medical Care” Peter Angelos, MD, PhD 9:15-9:45AM          “Use of Advanced Neuro-technologies in Managing Patients with Prolonged Disorders of Consciousness” Gilberto Leung, MD, PhD 9:45-10:15AM        “Ethical Issues in the Treatment of a Common Condition in Hospitalized Patients” Micah Prochaska, MD 10:15-10:45AM      Coffee/Tea Break...

WYNG-HATTON Lecture 2024: Artificial Intelligence Policy as a Contact Sport: Why Bioethics and Governance Need to up Their Game in the Health Sector (Hosted by CMEL’s Collaborator, PHG Foundation)

Video recording (click here to watch on YouTube)  Abstract: The proposed uses of AI in the health sector have elicited reactions from hope to handwringing to hype. In response, governments, NGOs, professional organizations, and the standards community have been busy developing guidelines, frameworks, principles, and other oversight tools with the laudable intention of crafting responsible governance policy for AI in health. Yet with so many players and documents in circulation, it is not...

Skip to content